Biotech Week Boston is a collection of several industry-leading events, including BioProcess International, Cell & Gene Therapy Manufacturing & Commercialization US, and TIDES USA. The event was held at the Boston Convention Center from September 21-23. In attendance were life science professionals with expertise in discovery, financing, manufacturing, and clinical trials.

We caught up with the following experts:

• Stefano Menegatti, associate professor at North Carolina State University
• Armon Sharei, founder and CEO of SQZ Biotech
• Fabian Gerlinghaus, co-founder and CEO of Cellares
• Andrew Tustian, director of viral process development at Regeneron Pharmaceuticals

High-throughput analysis speeds downstream process development
Adding high-throughput analysis helped speed up downstream process development for drug candidates based on monoclonal antibodies, according to a case...

Optofluidics aids cell line development for antibody-based therapies
Implementation of optofluidics in cell line development can help advance multiple lead candidate molecules with increased screening capacity. A researcher...